Nuzenio

Alphamab

Alphamab news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 14 publisher sources 100/100 entity strength

Latest news

Alphamab’s Anbenitamab Breast Cancer NDA Gains Priority Review in China - TipRanksTipRanks · Tue, 04 Aug 2026 23:16:06 GMTPathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents - medcitynews.commedcitynews.com · Tue, 04 Aug 2026 20:22:15 GMTPathos AI Licenses Alphamab's TROP2/HER3 Bispecific ADC, JSKN016 - BioPharm InternationalBioPharm International · Tue, 04 Aug 2026 17:01:14 GMTPathos AI inks deals with AstraZeneca and Alphamab - thepharmaletter.comthepharmaletter.com · Tue, 04 Aug 2026 14:40:35 GMTM&A Roundup: Pathos AI Enter’s Licensing Agreements with AstraZeneca & Alphamab Oncology, Curium Enters Merger Agreement with Lantheus - Pharmaceutical ExecutivePharmaceutical Executive · Tue, 04 Aug 2026 14:07:34 GMTPathos AI Secures Global Rights to Alphamab's Experimental Breast Cancer Drug in Up to $1.5 Billion Deal - Voice of HealthcareVoice of Healthcare · Tue, 04 Aug 2026 13:55:12 GMTPathos inks back-to-back cancer contracts with AstraZeneca, China’s Alphamab - BioSpaceBioSpace · Tue, 04 Aug 2026 12:15:52 GMTPathos AI strikes deals with Alphamab and AstraZeneca to build AI-native oncology pipeline - Manufacturing ChemistManufacturing Chemist · Tue, 04 Aug 2026 12:09:55 GMT

Timeline

Tue, 04 Aug 2026 23:16:06 GMTAlphamab’s Anbenitamab Breast Cancer NDA Gains Priority Review in China - TipRanks
Tue, 04 Aug 2026 20:22:15 GMTPathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents - medcitynews.com
Tue, 04 Aug 2026 17:01:14 GMTPathos AI Licenses Alphamab's TROP2/HER3 Bispecific ADC, JSKN016 - BioPharm International
Tue, 04 Aug 2026 14:40:35 GMTPathos AI inks deals with AstraZeneca and Alphamab - thepharmaletter.com
Tue, 04 Aug 2026 14:07:34 GMTM&A Roundup: Pathos AI Enter’s Licensing Agreements with AstraZeneca & Alphamab Oncology, Curium Enters Merger Agreement with Lantheus - Pharmaceutical Executive
Tue, 04 Aug 2026 13:55:12 GMTPathos AI Secures Global Rights to Alphamab's Experimental Breast Cancer Drug in Up to $1.5 Billion Deal - Voice of Healthcare

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Alphamab.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.